Table 5.
Laboratory and radiological characteristics of the COVID-19 groups
| Studied variables | COVID-19 groups | Test f sig. | P value | |
|---|---|---|---|---|
| Group I N = 295 |
Group II N = 103 |
|||
| Hb (11–13 g/dL) | ||||
| Mean ± SD | 11.38 ± 1.86 | 10.46 ± 1.15 | 6.31 | < 0.001** |
| Median (Range) | 11.5 (4.5–14) | 10.5 (8.2–12) | ||
| WBCs (5.5–15.5 × 103 / μL) | ||||
| Mean ± SD | 10.91 ± 4.952 | 7.22 ± 5.013 | 3.1 | 0.002* |
| Median (Range) | 4 (2.400–11.00) | 4.300 (3.200–7.700) | ||
| ANC (1.5–7.5 × 103/μL) | ||||
| Mean ± SD | 4.51 ± 1.24 | 4.03 ± 2.64 | 4.06 | < 0.001** |
| Median (Range) | 2.20 (1.0–6.30) | 2.50 (2.00–4.20) | ||
| Lymphocytes (1.5–8.5 × 103/μL) | ||||
| Mean ± SD | 2.51 ± 1.21 | 1.140 ± 0.51 | 2.13 | 0.03* |
| Median (Range) | 0.90 (0.10–3.40) | 1 (0.50–2.40) | ||
| Platelets (150–450 × 103/μL) | ||||
| Mean ± SD | 210.46 ± 76.55 | 179.28 ± 67.37 | 5.13 | < 0.001** |
| Median (Range) | 212 (10–344) | 191 (34–313) | ||
| CRP (0–5.00 mg/L) | ||||
| Mean ± SD | 76.58 ± 56.88 | 78.44 ± 43.53 | 2.15 | 0.03* |
| Median (Range) | 77 (0–270) | 98 (0–148) | ||
| ESR (0–10 mm/hr.) | ||||
| Mean ± SD | 32.52 ± 13.08 | 27.82 ± 13.11 | 3.15 | 0.002* |
| Median (Range) | 35 (15–55) | 25 (15–50) | ||
| Ferritin (7–140 ng/ml) | ||||
| Mean ± SD | 453.99 ± 405.27 | 438.41 ± 218.50 | 3.72 | < 0.001** |
| Median (Range) | 300 (95–4000) | 480 (90–700) | ||
| D-dimer (< 0.5 μg/ml) | ||||
| Mean ± SD | 0.881 ± 0.591 | 1.196 ± 0.849 | 2.09 | 0.04* |
| Median (Range) | 1.4 (1.7–3.3) | 1 (1.7–5) | ||
| CT finding: N (%) | ||||
| Null | 235 (79.7%) | 16 (15.5%) | ||
| Ground-glass opacities | 36 (12.2%) | 70 (68.0%) | 144.1 | < 0.001** |
| Crazy paving pattern | 24 (8.1%) | 17 (16.5%) | ||